Abstract:The BMI1 protein contributes to stem cell pluripotency and oncogenesis via multiple functions, including its newly identified role in DNA damage response (DDR). Although evidence clearly demonstrates that BMI1 facilitates the repair of double-stranded breaks via homologous recombination (HR), it remains unclear how BMI1 regulates checkpoint activation during DDR. We report here that BMI1 has a role in G2/M checkpoint activation in response to etoposide (ETOP) treatment. Ectopic expression of BMI1 in MCF7 breast cancer and DU145 prostate cancer cells significantly reduced ETOP-induced G2/M arrest. Conversely, knockdown of BMI1 in both lines enhanced the arrest. Consistent with ETOP-induced activation of the G2/M checkpoints via the ATM pathway, overexpression and knockdown of BMI1, respectively, reduced and enhanced ETOP-induced phosphorylation of ATM at serine 1981 (ATM pS1981). Furthermore, the phosphorylation of ATM targets, including γH2AX, threonine 68 (T68) on CHK2 (CHK2 pT68) and serine 15 (S15) on p53 were decreased in overexpression and increased in knockdown BMI1 cells in response to ETOP. In line with the requirement of NBS1 in ATM activation, we were able to show that BMI1 associates with NBS1 and that this interaction altered the binding of NBS1 with ATM. BMI1 consists of a ring finger (RF), helix-turn-helix-turn-helix-turn (HT), proline/serine (PS) domain and two nuclear localization signals (NLS). Although deletion of either RF or HT did not affect the association of BMI1 with NBS1, the individual deletions of PS and one NLS (KRMK) robustly reduced the interaction. Stable expression of these BMI1 mutants decreased ETOP-induced ATM pS1981 and CHK2 pT68, but not ETOP-elicited γH2AX in MCF7 cells. Furthermore, ectopic expression of BMI1 in non-transformed breast epithelial MCF10A cells also compromised ETOP-initiated ATM pS1981 and γH2AX. Taken together, we provide compelling evidence that BMI1 decreases ETOP-induced G2/M checkpoint activation via reducing NBS1-mediated ATM activation.

CKIP-1 recruits nuclear ATM partially to the plasma membrane through interaction with ATM

AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation

Ckip-1: A Scaffold Protein and Potential Therapeutic Target Integrating Multiple Signaling Pathways and Physiological Functions

AIP1 is Critical in Transducing IRE1-mediated Endoplasmic Reticulum Stress Response

DAB2IP Coordinates Both PI3K-Akt and ASK1 Pathways for Cell Survival and Apoptosis

Role for the Pleckstrin Homology Domain-Containing Protein CKIP-1 in AP-1 Regulation and Apoptosis.

N-terminal PH Domain and C-terminal Auto-Inhibitory Region of CKIP-1 Coordinate to Determine Its Nucleus-Plasma Membrane Shuttling

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation

BMI1 Attenuates Etoposide-Induced G2/M Checkpoints Via Reducing ATM Activation.

CKIP-1 Inhibits Cardiac Hypertrophy by Regulating Class II Histone Deacetylase Phosphorylation Through Recruiting PP2A.

ATM and P21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development.

ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress.

Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM

The DNA repair kinase ATM regulates CD13 expression and cell migration

The PH Domain Containing Protein CKIP-1 Binds to IFP35 and Nmi and is Involved in Cytokine Signaling.

ATM modulates nuclear mechanics by regulating lamin A levels

Ataxia-Telangiectasia Mutated Is Involved in Autolysosome Formation

Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective

CKIP-1 mediates CK2 translocation to regulate Nav1.5 and Kir2.1 channel complexes in cardiomyocytes

Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma